Iovance Biotherapeutics appoints Timothy Morris CFO

15:29 EDT 10 Aug 2017 | CentreWatch

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, announced the appointment of Timothy E. Morris as Chief Financial Officer of the company, effective August 14, 2017. Morris has over 30 years of strategic financial and operating experience in the biotechnology sector. “We are very pleased to welcome Tim […]

The post Iovance Biotherapeutics appoints Timothy Morris CFO appeared first on CenterWatch News Online.

Original Article: Iovance Biotherapeutics appoints Timothy Morris CFO


More From BioPortfolio on "Iovance Biotherapeutics appoints Timothy Morris CFO"

Quick Search

Relevant Topics

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...